Pharmaceuticals in South Korea
June 2018
41
About the Report
About the Report
Pharmaceuticals in South Korea
Summary
Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
Essential resource for top-line data and analysis covering the South Korea pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Key highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The South Korean pharmaceuticals market had total revenues of USD 19.1bn in 2017, representing a compound annual growth rate (CAGR) of 2.3% between 2013 and 2017.
- South Korea has been classed as a developed pharmaceuticals market since 2010. As such it suffers classic problems that other developed markets are experiencing which will lead to increased spending.
- Despite an aging population and being one of the most sophisticated healthcare systems in the world, the value of the pharmaceutical market is only forecast to accelerate slightly throughout the forecast period.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Korea
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Korea
- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South Korea pharmaceuticals market with five year forecasts
Reasons to buy
- What was the size of the South Korea pharmaceuticals market by value in 2017?
- What will be the size of the South Korea pharmaceuticals market in 2022?
- What factors are affecting the strength of competition in the South Korea pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in South Korea's pharmaceuticals market?
Products
Table of Contents
Table of Contents
Table of Contents
Executive Summary 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 9
Market value 9
Market Segmentation 10
Geography segmentation 10
Market share 11
Market Outlook 12
Market value forecast 12
Five Forces Analysis 13
Summary 13
Buyer power 14
Supplier power 16
New entrants 17
Threat of substitutes 19
Degree of rivalry 20
Leading Companies 22
CKD Bio Corporation 22
Daewoong Pharmaceutical Co Ltd 25
Hanmi Science Co., Ltd. 29
Pfizer Inc. 32
Macroeconomic Indicators 36
Country data 36
Methodology 38
Industry associations 39
Related MarketLine research 39
Appendix 40
About MarketLine 40
List of Figure
List of Figures
Figure 1: South Korea pharmaceuticals market value: USD billion, 2013-17
Figure 2: South Korea pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: South Korea pharmaceuticals market share: % share, by value, 2017
Figure 4: South Korea pharmaceuticals market value forecast: USD billion, 2017-22
Figure 5: Forces driving competition in the pharmaceuticals market in South Korea, 2017
Figure 6: Drivers of buyer power in the pharmaceuticals market in South Korea, 2017
Figure 7: Drivers of supplier power in the pharmaceuticals market in South Korea, 2017
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2017
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2017
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2017
Figure 11: CKD Bio Corporation: revenues & profitability
Figure 12: CKD Bio Corporation: assets & liabilities
Figure 13: Daewoong Pharmaceutical Co Ltd: revenues & profitability
Figure 14: Daewoong Pharmaceutical Co Ltd: assets & liabilities
Figure 15: Hanmi Science Co., Ltd.: revenues & profitability
Figure 16: Hanmi Science Co., Ltd.: assets & liabilities
Figure 17: Pfizer Inc.: revenues & profitability
Figure 18: Pfizer Inc.: assets & liabilities
List of Table
List of Tables
Table 1: South Korea pharmaceuticals market value: USD billion, 2013-17
Table 2: South Korea pharmaceuticals market geography segmentation: USD billion, 2017
Table 3: South Korea pharmaceuticals market share: % share, by value, 2017
Table 4: South Korea pharmaceuticals market value forecast: USD billion, 2017-22
Table 5: CKD Bio Corporation: key facts
Table 6: CKD Bio Corporation: key financials (USD )
Table 7: CKD Bio Corporation: key financials (KRW)
Table 8: CKD Bio Corporation: key financial ratios
Table 9: Daewoong Pharmaceutical Co Ltd: key facts
Table 10: Daewoong Pharmaceutical Co Ltd: key financials (USD )
Table 11: Daewoong Pharmaceutical Co Ltd: key financials (KRW)
Table 12: Daewoong Pharmaceutical Co Ltd: key financial ratios
Table 13: Hanmi Science Co., Ltd.: key facts
Table 14: Hanmi Science Co., Ltd.: key financials (USD )
Table 15: Hanmi Science Co., Ltd.: key financials (KRW)
Table 16: Hanmi Science Co., Ltd.: key financial ratios
Table 17: Pfizer Inc.: key facts
Table 18: Pfizer Inc.: key financials (USD )
Table 19: Pfizer Inc.: key financial ratios
Table 20: South Korea size of population (million), 2013-17
Table 21: South Korea gdp (constant 2005 prices, USD billion), 2013-17
Table 22: South Korea gdp (current prices, USD billion), 2013-17
Table 23: South Korea inflation, 2013-17
Table 24: South Korea consumer price index (absolute), 2013-17
Table 25: South Korea exchange rate, 2013-17
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.